[1]
Julia Świechowska, “MID-REGIONAL PRO-ADRENOMEDULLIN (MR-proADM) AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN EARLY SEPSIS: A NARRATIVE REVIEW”, IJITSS, vol. 2, no. 2(50), Jun. 2026, doi: 10.31435/ijitss.2(50).2026.5741.